In an effort to hold onto sales of cholesterol fighter Lipitor after the drug loses patent protection at the end of this month, Pfizer is planning to sell the pills at generic prices directly to patients.
Pfizer to sell Lipitor directly to patients
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.